I can hardly think that the placebo arm of this trial would simply be to withold the injection of DCVax.
I have always understood that both arms of a placebo-controlled trial had to be identical except for the actual agent. Those who were assigned to the active arm got the active drug whilst those assigned to the placebo arm were given a superficially identical treatment but with no active agent.
One of the problems of making this a placebo-controlled trial was the development of a suitable placebo which was sufficiently like the real stuff so that nobody could tell which injection was DCVax and which was placebo.
Simply not giving a treatment immediately negates such a trial as everybody, and especially the patient, knows that they are getting no treatment and so there cannot be a placebo effect in the first place. So, there would be no placebo arm - just a no treatment arm. There would be nothing to assess the placebo effect and nobody would really know just how much of the observed benefit of a treatment was due to the active agent being trialled and how much benefit was due to the placebo effect.